시장보고서
상품코드
1193142

전자후두(일렉트로래링크스) 시장 : 유형별(내장 배터리, 외부 배터리), 용도별(후두암, 언어 재활), 최종 사용자별(병원, 외래 수술 센터, 기타) - 세계 기회 분석 및 산업 예측(2021-2031년)

Electrolarynx Market By Type (Built-in Battery, External Battery), By Application (Laryngeal Cancer, Speech Rehabilitation), By End user (Hospitals, Ambulatory Surgical Centers, others): Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 190 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전자후두의 세계 시장은 2021년에 4억 950만 달러, 2031년에는 7억 300만 달러에 이를 것으로 예측되며, 2022년부터 2031년에 걸쳐 CAGR 5.5%로 성장하고 있습니다.

전자후두 (일렉트로래링크스)는 사람이 말할 수 있도록 소리를 발생시키는 배터리 구동 장치입니다. 다양한 메이커나 모델이 있습니다만, 일반적으로는 소형의 전기 면도기 정도의 크기입니다. 사람이 말하고 싶을 때,이 작은 배터리 소품을 목 턱 아래에 착용하십시오. 버튼을 누르면 진동이 피부에서 목에 전달됩니다. 그 소리를 입, 혀, 입술, 치아로 표현하고 말로 합니다.

인공 후두는 목소리를 잃은 사람이 음성의 주파수 파라미터를 조정하고 저장함으로써 더 나은 발성을 할 수 있도록 하는 장치입니다. 음성 복원 장치는 후두라고 불리는 성대 전체를 영구적으로 절제하고 기관과 식도를 분리하는 후두 절제술 후에 가장 활용됩니다.

시장 성장을 촉진하는 중요한 요인은 후두암의 유병률 증가와 알코올과 담배 소비의 급증은 electrolarynx 시장을 구동하는 주요 요인입니다. 예를 들어 미국암협회가 발표한 보고서에 따르면 2022년 미국에서 후두암에 대해서는 새로 약 12,470명(남성 9,820명, 여성 2,650명)이 후두암으로 사망한 것으로 추정되고 있습니다( 3,070 남성, 750 여성). 또한, 인유두종 바이러스(HPV)에 의해 유발되는 호흡기 유두종의 증례가 증가하는 것은 보통 양성(암이 아님)임을 나타냅니다. 이 종양은 성대의 손상과기도 문제로 이어질 수 있으며 전자후두 장치의 수요를 증가시키고 시장 성장을 촉진합니다. 게다가 이러한 의료기기의 높은 채용률과 혁신적이고 기술적으로 첨단 전자후두장치의 출시를 위해 많은 선수들의 연구개발에 대한 지속적인 투자는 시장 성장을 촉진 예상됩니다.

그러나 전자후두 장치의 비용이 높다는 것은 시장 성장을 방해합니다. 반대로 하인두암의 증례수 증가, 신흥국의 헬스케어 시장의 대두, 기본적인 헬스케어에 대한 액세스가 없는 저소득국가, 후두암의 리스크 증가는 예측기간 동안 시장 성장을 위한 유리한 기회를 제공할 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석

제4장 전자후두(일렉트로래링크스) 시장 : 유형별

  • 개요
    • 시장 규모·예측
  • 내장형 배터리
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 외장 배터리
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제5장 전자후두(일렉트로래링크스) 시장 : 용도별

  • 개요
    • 시장 규모·예측
  • 후두암
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 연설 재활
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제6장 전자후두(일렉트로래링크스) 시장 : 최종 사용자별

  • 개요
    • 시장 규모·예측
  • 병원
    • 주요 시장 동향, 성장 요인과 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 외래 수술 센터
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제7장 전자후두(일렉트로래링크스) 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 유형별
    • 북미 시장 규모·예측 : 용도별
    • 북미 시장 규모·예측 : 최종 사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽의 시장 규모·예측 : 유형별
    • 유럽 시장 규모·예측 : 용도별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽 지역
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 유형별
    • 아시아태평양의 시장 규모·예측 : 용도별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 일본
      • 중국
      • 호주
      • 인도
      • 한국
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 유형별
    • LAMEA의 시장 규모·예측 : 용도별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카 공화국
      • 기타 LAMEA 지역

제8장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경합의 히트 맵
  • 주요 발전

제9장 기업 프로필

  • Ultravoice Limited
  • Inhealth Technologies
  • Griffin Labs
  • Servona GmbH
  • Labex Trade
  • AMPLICORD DI GABRIELLA SALVATORE
  • Romet Limted
  • Nu-Vois, LLC
  • Andreas Fahl Medizintechnik-Vertrieb GmbH
  • Atos Medical AB
ksm 23.03.27

The global electrolarynx market was valued at $409.5 million in 2021 and is projected to reach $703.0 million by 2031, registering a CAGR of 5.5% from 2022 to 2031. An electronic larynx (electrolarynx) is battery-powered equipment that generates sound so that a person can speak. There are various makes and models, but they are typically the size of a small electric razor. When a person wants to talk, this little, battery-operated gadget is put right on the neck, beneath the chin. The electrolarynx produces a vibration that is sent via the skin to the throat when a person presses a button on the device. With the mouth, tongue, lips, and teeth, the patient forms this sound into words.

The artificial larynx device allows individuals who have lost their voice to adjust and save several sound frequency parameters to produce improved speech. Voice restoration devices are most utilized after a laryngectomy, in which the whole voice box, known as the larynx, is permanently removed, separating the windpipe and food pipe.

The key factors that drive the growth of the market are the rise in the prevalence of laryngeal cancer and the surge in the consumption of alcohol and tobacco are the major factors drive the electrolarynx market. For instance, according to the report published by the American Cancer Society, it has been estimated for laryngeal cancer in the U.S. for 2022 that, about 12,470 new cases of laryngeal cancer (9,820 in men and 2,650 in women) were recorded in about 3,820 people (3,070 men and 750 women) died from laryngeal cancer. Furthermore, the increase in the cases of respiratory papilloma which is caused by the human papillomavirus (HPV) is usually benign (non-cancerous). These growths can lead to vocal cord damage and airway problems, which increases the demand for electrolarynx devices hence propelling the growth of the market. Moreover, the high adoption of these medical devices and continuously investing in R&D by numerous key players for the launch of innovative and technologically advanced electrolarynx devices are anticipated to fuel the market growth.

However, the high cost of electrolarynx devices hampers market growth. Conversely, rising cases of hypopharyngeal cancer, the emerging healthcare market in developing countries, and low-income countries lacking access to basic healthcare, and an increase in the risk of laryngeal cancer are expected to provide a lucrative opportunity for the growth of the market during the forecast period. 

The electrolarynx market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into external batteries and built-in batteries. By application, it is bifurcated into laryngeal cancer and speech rehabilitation. By end user, the market is segmented into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. The electrolarynx market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of laryngeal cancer. Moreover, an increase in the number of people consuming alcohol and tobacco and a rise in the demand for electrolarynx devices are contributing to the market growth in the region. Furthermore, an increasing number of key players in this region are involved in R&D activities for the development of technologically advanced medical devices, and the initiatives being undertaken by various organizations to spread awareness and reduce the prevalence rate of hypopharyngeal cancer through innovative research are expected to fuel the market growth.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, the rapidly growing population, various lifestyle changes such as the high rate of people consuming alcohol and tobacco, rising incidence of laryngeal cancer, improvement in the quality of diagnosis, and increasing patient affordability are set to drive the market in the Asia-Pacific region. This helps several market players to invest in Asia-Pacific countries, which in turn will further contribute to the growth of the market.

The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Fountain Head Marketing, Inc., Medline Industries, Nu Vois, Labaex, InHealth Technologies, Romet, Servona GmbH, Luminaud, and Ultravoice.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electrolarynx market analysis from 2021 to 2031 to identify the prevailing electrolarynx market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the electrolarynx market segmentation assists in determining the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes an analysis of the regional as well as global electrolarynx market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Built-in Battery
  • External Battery

By Application

  • Laryngeal Cancer
  • Speech Rehabilitation

By End user

  • Hospitals
  • Ambulatory Surgical Centers
  • others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Ultravoice Limited
    • Inhealth Technologies
    • Griffin Labs
    • Servona GmbH
    • Labex Trade
    • AMPLICORD DI GABRIELLA SALVATORE
    • Romet Limted
    • Nu-Vois, LLC
    • Andreas Fahl Medizintechnik - Vertrieb GmbH
    • Atos Medical AB

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ELECTROLARYNX MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Built-in Battery
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 External Battery
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: ELECTROLARYNX MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Laryngeal Cancer
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Speech Rehabilitation
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: ELECTROLARYNX MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: ELECTROLARYNX MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End user
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Type
      • 7.2.5.1.3 Market size and forecast, by Application
      • 7.2.5.1.4 Market size and forecast, by End user
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Type
      • 7.2.5.2.3 Market size and forecast, by Application
      • 7.2.5.2.4 Market size and forecast, by End user
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Type
      • 7.2.5.3.3 Market size and forecast, by Application
      • 7.2.5.3.4 Market size and forecast, by End user
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End user
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Type
      • 7.3.5.1.3 Market size and forecast, by Application
      • 7.3.5.1.4 Market size and forecast, by End user
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Type
      • 7.3.5.2.3 Market size and forecast, by Application
      • 7.3.5.2.4 Market size and forecast, by End user
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Type
      • 7.3.5.3.3 Market size and forecast, by Application
      • 7.3.5.3.4 Market size and forecast, by End user
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Type
      • 7.3.5.4.3 Market size and forecast, by Application
      • 7.3.5.4.4 Market size and forecast, by End user
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Type
      • 7.3.5.5.3 Market size and forecast, by Application
      • 7.3.5.5.4 Market size and forecast, by End user
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Type
      • 7.3.5.6.3 Market size and forecast, by Application
      • 7.3.5.6.4 Market size and forecast, by End user
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End user
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Type
      • 7.4.5.1.3 Market size and forecast, by Application
      • 7.4.5.1.4 Market size and forecast, by End user
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Type
      • 7.4.5.2.3 Market size and forecast, by Application
      • 7.4.5.2.4 Market size and forecast, by End user
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Type
      • 7.4.5.3.3 Market size and forecast, by Application
      • 7.4.5.3.4 Market size and forecast, by End user
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Type
      • 7.4.5.4.3 Market size and forecast, by Application
      • 7.4.5.4.4 Market size and forecast, by End user
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Type
      • 7.4.5.5.3 Market size and forecast, by Application
      • 7.4.5.5.4 Market size and forecast, by End user
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Type
      • 7.4.5.6.3 Market size and forecast, by Application
      • 7.4.5.6.4 Market size and forecast, by End user
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End user
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Type
      • 7.5.5.1.3 Market size and forecast, by Application
      • 7.5.5.1.4 Market size and forecast, by End user
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Type
      • 7.5.5.2.3 Market size and forecast, by Application
      • 7.5.5.2.4 Market size and forecast, by End user
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Type
      • 7.5.5.3.3 Market size and forecast, by Application
      • 7.5.5.3.4 Market size and forecast, by End user
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Type
      • 7.5.5.4.3 Market size and forecast, by Application
      • 7.5.5.4.4 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Ultravoice Limited
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Inhealth Technologies
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Griffin Labs
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Servona GmbH
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Labex Trade
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 AMPLICORD DI GABRIELLA SALVATORE
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Romet Limted
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Nu-Vois, LLC
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Andreas Fahl Medizintechnik - Vertrieb GmbH
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Atos Medical AB
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제